Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TSG101 Antikörper (AA 229-319)

TSG101 Reaktivität: Human, Maus, Ratte, Hund WB Wirt: Maus Monoclonal 51-TSG101 unconjugated
Produktnummer ABIN968912
  • Target Alle TSG101 Antikörper anzeigen
    TSG101 (Tumor Susceptibility Gene 101 (TSG101))
    Bindungsspezifität
    • 14
    • 11
    • 10
    • 8
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 229-319
    Reaktivität
    • 81
    • 42
    • 31
    • 11
    • 8
    • 8
    • 8
    • 8
    • 6
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    Human, Maus, Ratte, Hund
    Wirt
    • 72
    • 12
    Maus
    Klonalität
    • 63
    • 21
    Monoklonal
    Konjugat
    • 49
    • 6
    • 5
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser TSG101 Antikörper ist unkonjugiert
    Applikation
    • 69
    • 39
    • 30
    • 12
    • 12
    • 10
    • 6
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Kreuzreaktivität
    Maus, Ratte (Rattus), Hund
    Produktmerkmale
    1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
    2. Please refer to us for technical protocols.
    3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
    4. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
    Aufreinigung
    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
    Immunogen
    Human TSG101 aa. 229-319
    Klon
    51-TSG101
    Isotyp
    IgG1
    Top Product
    Discover our top product TSG101 Primärantikörper
  • Kommentare

    Related Products: ABIN968586, ABIN967389

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    250 μg/mL
    Buffer
    Aqueous buffered solution containing BSA, glycerol, and ≤0.09 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store undiluted at -20° C.
  • Li, Liao, Ruland, Mak, Cohen: "A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 4, pp. 1619-24, (2001) (PubMed).

    Zhong, Chen, Chen, Chen, Lee: "Identification of cellular TSG101 protein in multiple human breast cancer cell lines." in: Cancer research, Vol. 57, Issue 19, pp. 4225-8, (1997) (PubMed).

    Li, Cohen: "Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells." in: Cell, Vol. 85, Issue 3, pp. 319-29, (1996) (PubMed).

  • Target
    TSG101 (Tumor Susceptibility Gene 101 (TSG101))
    Andere Bezeichnung
    TSG101 (TSG101 Produkte)
    Synonyme
    CG9712 antikoerper, DmTSG101 antikoerper, Dmel\\CG9712 antikoerper, ESCRT-I antikoerper, Tsg101 antikoerper, burs antikoerper, dTSg101 antikoerper, dTsg101 antikoerper, dVps23 antikoerper, ept antikoerper, tsg101 antikoerper, vps23 antikoerper, TSG101 antikoerper, MGC76193 antikoerper, TSG10 antikoerper, VPS23 antikoerper, AI255943 antikoerper, CC2 antikoerper, Rw antikoerper, zgc:86926 antikoerper, tumor susceptibility 101 antikoerper, Tumor susceptibility gene 101 antikoerper, Tumor Susceptibility Gene homolog antikoerper, tumor susceptibility gene 101 antikoerper, tumor susceptibility 101a antikoerper, tumor susceptibility 101 L homeolog antikoerper, TSG101 antikoerper, tsg-101 antikoerper, tsg101 antikoerper, Tsg101 antikoerper, tsg101a antikoerper, tsg101.L antikoerper
    Hintergrund
    Tumor Susceptibility Gene 101 (TSG101) was identified in a random mutagenesis screen for potential tumor suppressors in NIH 3T3 cells. Altered transcripts of this gene have been detected in sporadic breast cancers and many other human malignancies. Though the function of TSG101 is not clearly understood, its protein structure includes motifs involved in transcription regulation, and TSG101 has been shown to modulate the activation of steroid hormone receptors. In addition, TSG101 may have a role in regulating ubiquination. The N-terminal region of TSG101 contains a domain that resembles the catalytically active region of ubiquitin conjugases. However, TSG101 lacks an active-site cysteine crucial to the function of these conjugases. Interestingly, TSG101 interferes with MDM2 ubiquination leading to a decrease in MDM2 decay and down-regulation of p53 protein. Thus, TSG101 may function as a dominant-negative inhibitor of ubiquination in pathways where protein expression is tightly regulated.
    Synonyms: Tumor Susceptibility Gene 101
    Molekulargewicht
    46 kDa
Sie sind hier:
Kundenservice